Vertex Pharmaceuticals (NASDAQ: VRTX) has not performed well for most of the year, and the company's latest quarterly update ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in Citi’s 2025 Global Healthcare ...

Microsoft customers worldwide can now discover Vertex Configuration Agent through Microsoft Marketplace, accessing trusted ...

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best gene-editing stocks to buy according to hedge funds.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Vertex, Inc. (NASDAQ:VERX) experienced a price target cut on November 5, 2025, with Goldman Sachs lowering its target from ...

Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...

Tylah Tully looks at Vertex Minerals and the increasingly alluring gold grades coming out of its Reward gold mine in New ...

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

Vertex Resource Group Ltd. ("Vertex" or the "Company") reports its financial and operational results for the third quarter ...

Vertex Pharmaceuticals Incorporated (VRTX) is a leading U.S. biopharmaceutical company, headquartered in Boston, ...